Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combination of Alpha Interferon With Long Term Ribavirin Therapy for Patients With Chronic Hepatitis C

NCT00001729 is registered in ClinicalTrials.gov with National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) as lead sponsor.

NCT NCT00001729
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00001729 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combination of Alpha Interferon With Long Term Ribavirin Therapy for Patients With Chronic Hepatitis C
Lead sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase
Phase 3
Overall status
Completed
Start date
October 31, 1997
Completion date
September 30, 2002
Enrollment
120
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hepatitis c, fibrosis, hemolytic anemia